Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Brain (and spinal cord) tumours
Closed
Phase 1
This trial is looking at whether a drug called olaparib improves the way radiotherapy and chemotherapy work. It is for people with a type of brain tumour called glioblastoma who:
are newly diagnosed
have recently had surgery
Cancer Research UK supports this trial.
Recruitment start: 15 November 2016
Recruitment end: 31 December 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Anthony Chalmers
Cancer Research UK
AstraZeneca
NHS Greater Glasgow and Clyde
The Brain Tumour Charity
University of Glasgow
This is Cancer Research UK trial number CRUKD/16/010.
Last reviewed: 2 January 2025
CRUK internal database number: 14194